Vincerx Pharma Inc share price logo

Vincerx Pharma Inc

OTC: VINC

$0.01

-0.01

(-41.63%)

as on

Vincerx Pharma Inc Stock Performance

as on October 17, 2026 at 4:47 am IST

  • Day's Low

    Day's High

    $0.01
    $0.01
    downward going graph

    33.33%

    Downside

    -33.33%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.00
    $0.05
    downward going graph

    98.67%

    Downside

    200.00%

    Upside

    downward going graph

Vincerx Pharma Inc share price movements today

Previous Close
$0.03
Open
$0.01
Volume
9.6K
Market Cap
$68.0K
Day's Low - High
$0.01 - $0.01
52 Week Low - High
$0.00 - $0.05

Vincerx Pharma Inc Historical Returns

1 Month Return
0 %
3 Month Return
-0.66 %
1 Year Return
-53.12 %
3 Year Return
-99.92 %
5 Year Return
-99.99 %

Vincerx Pharma Inc Stock Fundamentals & Key Indicators

Check Vincerx Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$68.0K

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0.00

EBITDA

-24.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-3136.43%

Vincerx Pharma Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Vincerx Pharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$68.0K-99.99%NA0.00%0.00%

Stock Returns calculator for Vincerx Pharma Inc Stock including INR - Dollar returns

The Vincerx Pharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Vincerx Pharma Inc investment value today

Current value as on today

₹50,638

Returns

-₹49,362

(-49.36%)

Returns from Vincerx Pharma Inc Stock

-₹53,125 (-53.13%)

Dollar Impact

₹3,763 (+3.76%)

Analyst Recommendation on Vincerx Pharma Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Vincerx Pharma Inc. Average target price of $200

Vincerx Pharma Inc Share Price Target

Get share price movements and forecasts by analysts on Vincerx Pharma Inc.

What analysts predicted

99.99%UPSIDE

Target Price

$200

Current Price

$0.015

Analyzed by

9 Analysts

Target

$200.00

Vincerx Pharma Inc target price $200, a slight upside of 99.99% compared to current price of $0.015. According to 9 analysts rating.

Vincerx Pharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Total Revenue
-
-
-
-
1
-
-
-
1
-
Gross Profit
0
0
0
0
1
0
0
0
0
-
Operating Income
-15
-15
-11
-10
-5
-7
-7
-7
-8
-3
EBITDA
-15
-15
-11
-10
-5
-7
-7
-7
-8
-3
Interest Expense
8
0
-
-
0
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-13
-14
-11
-9
-4
-12
-1
-7
-7
-5
Income Tax Expense
-8
0
0
0
1
0
-
-
0
-
Net Income
-5
-13
-11
-9
-4
-12
-1
-7
-7
-5
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-376.71%
0.00%
0.00%
0.00%
-748.50%
0.00%

Vincerx Pharma Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
Gross Profit
0
0
0
0
-1
Operating Income
-10
-62
-68
-42
-31
EBITDA
-10
-38
-62
-39
-31
Interest Expense
0
23
8
-
-
Depreciation
-
0
0
0
1
Income Before Tax
-10
-39
-62
-40
-30
Income Tax Expense
0
-23
-8
-
-
Net Income
-10
-39
-65
-40
-30
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Vincerx Pharma Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Net Income
-14
-11
-9
-4
-12
-1
-7
-7
-5
Operating Cash Flow
-13
-12
-6
-8
-7
-5
-6
-6
-4
Investing Cash Flow
5
14
15
5
-
-8
1
7
-
Financing Cash Flow
0
0
-
0
0
17
-
0
3
Change in Cash
-7
2
8
-2
-7
2
-4
2
0

Vincerx Pharma Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-10
-39
-65
-40
-30
Operating Cash Flow
-2
-33
-59
-40
-26
Investing Cash Flow
-65
-5
-40
41
0
Financing Cash Flow
64
88
0
0
17
Change in Cash
61
49
-99
1
-7

Global Institutional Holdings in Vincerx Pharma Inc

Check out the Institutions with significant holdings in Vincerx Pharma Inc.

Funds
Holdings
Bank & Trust Co
0.00%
SAGE RHINO CAPITAL LLC
1.63%
Rock Springs Capital Management LP
0.85%
Armistice Capital, LLC
0.54%
Geode Capital Management, LLC
0.23%

About Vincerx Pharma Inc

Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
OrganisationVincerx Pharma Inc
Headquarters1825 S Grant Street, Palo Alto, CA, 94402, US
IndustryBiotechnology
CEORaquel E. Izumi

Key Management of Vincerx Pharma Inc

Name

Title

Mr. Kevin Haas

Acting CFO, VP of Finance & Corporate Controller

Dr. Hans-Georg Lerchen Ph.D.

Chief Scientific Officer

Ms. Gabriela Jairala

VP of Investor Relations & Corporate Communications and Chief of Staff

Ms. Melissa Merrick SPHR

Senior Director of People & Culture and Head of Human Resource

Dr. Beatrix Stelte-Ludwig Ph.D.

Executive Chief Development Officer

Mr. Alexander A. Seelenberger M.B.A.

Consultant

Mr. Tom C. Thomas J.D.

Consultant

Dr. John C. Byrd M.D.

Founder & Chairman of Scientific Advisory Board

Ms. Karen Quarford M.B.A.

Vice President of Quality Operations & Compliance

Dr. Raquel E. Izumi Ph.D.

Co-Founder, Acting CEO, Secretary & Director

FAQs

What is Vincerx Pharma Inc share price today?

Vincerx Pharma Inc share price today is $0.02 as on at the close of the market. Vincerx Pharma Inc share today touched a day high of $0.01 and a low of $0.01.

What is the 52 week high and 52 week low for Vincerx Pharma Inc share?

Vincerx Pharma Inc share touched a 52 week high of $0.05 on and a 52 week low of $0.00 on . Vincerx Pharma Inc stock price today i.e. is closed at $0.02,which is 66.67% down from its 52 week high and 7400.00% up from its 52 week low.

What is Vincerx Pharma Inc's market capitalisation today?

Vincerx Pharma Inc market capitalisation is $0.00T as on .

How to invest in Vincerx Pharma Inc Stock (VINC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vincerx Pharma Inc on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Vincerx Pharma Inc Stock (VINC) from India?

Indian investors can start investing in Vincerx Pharma Inc (VINC) shares with as little as ₹94.93000030517578 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.30 in Vincerx Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Vincerx Pharma Inc share’s latest price of $0.02 as on October 16, 2026 at 11:17 pm IST, you will get 666.6667 shares of Vincerx Pharma Inc. Learn more about fractional shares .

What are the returns that Vincerx Pharma Inc has given to Indian investors in the last 5 years?

Vincerx Pharma Inc stock has given -99.99% share price returns and 26.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?